FDA approves treatment IND protocol for use of erythropoietin product in AIDS.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D002985:Clinical Protocols; D015507:Drugs, Investigational; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans
D015507:Drugs, Investigational; D004921:Erythropoietin